易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002826 易明医药

已收盘 02-13 15:00:00

{"stockData":{"symbol":"002826","market":"SZ","secType":"STK","nameCN":"易明医药","latestPrice":20.3,"timestamp":1770966186000,"preClose":20.79,"halted":0,"volume":5217600,"delay":0,"changeRate":-0.0236,"floatShares":174000000,"shares":191000000,"eps":0.4504,"marketStatus":"已收盘","change":-0.49,"latestTime":"02-13 15:00:00","open":20.8,"high":20.9,"low":20.29,"amount":107000000,"amplitude":0.0293,"askPrice":20.3,"askSize":130,"bidPrice":20.29,"bidSize":34,"shortable":0,"etf":0,"ttmEps":0.4504,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1771896600000},"marketStatusCode":5,"adr":0,"adjPreClose":20.79,"symbolType":"stock","openAndCloseTimeList":[[1770946200000,1770953400000],[1770958800000,1770966000000]],"highLimit":22.87,"lowLimit":18.71,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":190677750,"isCdr":false,"pbRate":4.94,"roa":"--","peRate":45.071048,"roe":"10.54%","epsLYR":0.25,"committee":0.553191,"marketValue":3871000000,"turnoverRate":0.0299,"status":1,"floatMarketCap":3539000000},"requestUrl":"/m/hq/s/002826","defaultTab":"news","newsList":[{"id":"2610946050","title":"易明医药(002826)2月10日股东户数1.77万户，较上期增加0.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610946050","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610946050?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:32","pubTimestamp":1770888772,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2026年2月10日公司股东户数为1.77万户，较1月30日增加31.0户，增幅为0.18%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至2月10日，化学制药行业平均股东户数为3.43万户。从股价来看，2026年1月30日至2026年2月10日，易明医药区间涨幅为10.87%，在此期间股东户数增加31.0户，增幅为0.18%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200028520.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","002826","BK0056"],"gpt_icon":0},{"id":"2609539451","title":"股市必读：易明医药（002826）2月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2609539451","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609539451?lang=zh_cn&edition=full","pubTime":"2026-02-05 01:50","pubTimestamp":1770227423,"startTime":"0","endTime":"0","summary":"截至2026年2月4日收盘，易明医药报收于21.24元，上涨1.24%，换手率10.64%，成交量18.55万手，成交额3.91亿元。董秘最新回复投资者： 最近股价回暖是否存在借壳预期？截至目前，公司未接到控股股东的相关指示，如有相关事项，公司将严格按照相关法律法规及时履行信息披露义务。请注意投资风险，感谢关注。交易信息汇总资金流向2月4日主力资金净流出550.76万元；游资资金净流出1747.68万元；散户资金净流入2298.44万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500001077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0239","BK0033","002826"],"gpt_icon":0},{"id":"2608821023","title":"易明医药：公司无原研药产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2608821023","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608821023?lang=zh_cn&edition=full","pubTime":"2026-02-04 08:57","pubTimestamp":1770166635,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)02月03日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司有什么样原研药产品呢，会加强在原研药的创新力度吗易明医药回复：尊敬的投资者，您好。公司无原研药产品。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400007581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0056","BK0033"],"gpt_icon":0},{"id":"2608438212","title":"易明医药：姚劲波先生作为公司的实际控制人","url":"https://stock-news.laohu8.com/highlight/detail?id=2608438212","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608438212?lang=zh_cn&edition=full","pubTime":"2026-02-04 08:55","pubTimestamp":1770166510,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)02月03日在投资者关系平台上答复投资者关心的问题。投资者提问：请问姚劲波先生参与公司管理吗易明医药回复：尊敬的投资者，您好。姚劲波先生作为公司的实际控制人，依照相关法规行使权利和履行义务，感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020400007569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0033","BK0239"],"gpt_icon":0},{"id":"2608171928","title":"异动快报：易明医药（002826）2月3日9点57分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2608171928","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608171928?lang=zh_cn&edition=full","pubTime":"2026-02-03 10:01","pubTimestamp":1770084064,"startTime":"0","endTime":"0","summary":"证券之星2月3日盘中消息，9点57分易明医药触及涨停板。其所属行业化学制药目前上涨。该股为西藏概念，医药，中药概念热股，当日西藏概念概念上涨0.8%，医药概念上涨0.44%，中药概念上涨0.24%。2月2日的资金流向数据方面，主力资金净流入352.65万元，占总成交额2.82%，游资资金净流入1244.17万元，占总成交额9.96%，散户资金净流出1596.83万元，占总成交额12.78%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300010674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0056","BK0033"],"gpt_icon":0},{"id":"2607072707","title":"易明医药最新公告：2025年净利同比预增61.12%—122.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607072707","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607072707?lang=zh_cn&edition=full","pubTime":"2026-01-29 17:41","pubTimestamp":1769679676,"startTime":"0","endTime":"0","summary":"易明医药(002826.SZ)发布业绩预告，预计2025年净利润7400万元—1.02亿元，同比增长61.12%—122.08%。报告期内，公司紧随行业发展方向及政策导向，集中资源大力发展自产产品，不断提升自产产品价值与市场占有率，实现了核心自有产品米格列醇片的销量增长，带动整体利润提升，为公司的长期稳定发展奠定基础。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900030098.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","002826","BK0056"],"gpt_icon":0},{"id":"2605446418","title":"易明医药(002826)1月20日股东户数1.84万户，较上期减少1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605446418","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605446418?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:42","pubTimestamp":1769074947,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2026年1月20日公司股东户数为1.84万户，较1月9日减少276.0户，减幅为1.48%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至1月20日，化学制药行业平均股东户数为3.43万户。从股价来看，2026年1月9日至2026年1月20日，易明医药区间涨幅为5.05%，在此期间股东户数减少276.0户，减幅为1.48%。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202601/22/20260122320308.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202601/22/20260122320308.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260122/31964287.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0056","BK0239","002826","BK0033"],"gpt_icon":0},{"id":"2603548666","title":"易明医药：截至2026年1月9日股东数为18,668户","url":"https://stock-news.laohu8.com/highlight/detail?id=2603548666","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603548666?lang=zh_cn&edition=full","pubTime":"2026-01-14 08:51","pubTimestamp":1768351865,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)01月13日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至1月10日的股东人数是多少？易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司最新下发的股东名册，截至2026年1月9日，本公司股东数为18,668户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400006687.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","BK0056","002826"],"gpt_icon":0},{"id":"2601481810","title":"股市必读：易明医药(002826)股东户数1.81万户，较上期增加0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601481810","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601481810?lang=zh_cn&edition=full","pubTime":"2026-01-07 04:03","pubTimestamp":1767729795,"startTime":"0","endTime":"0","summary":"截至2026年1月6日收盘，易明医药报收于18.42元，下跌0.05%，换手率2.02%，成交量3.52万手，成交额6524.05万元。交易信息汇总资金流向1月6日主力资金净流出182.16万元；游资资金净流入369.74万元；散户资金净流出187.58万元。股本股东变化股东户数变动近日易明医药披露，截至2025年12月31日公司股东户数为1.81万户，较12月19日增加45.0户，增幅为0.25%。户均持股数量由上期的1.06万股减少至1.05万股，户均持股市值为19.35万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010700001806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0056","BK0033"],"gpt_icon":0},{"id":"2601593558","title":"易明医药：截至2025年12月31日股东数为18,111户","url":"https://stock-news.laohu8.com/highlight/detail?id=2601593558","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601593558?lang=zh_cn&edition=full","pubTime":"2026-01-06 08:45","pubTimestamp":1767660310,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)01月05日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至12月31日的股东人数是多少？谢谢易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2025年12月31日，本公司股东数为18,111户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600006937.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","BK0239","002826"],"gpt_icon":0},{"id":"2601886024","title":"股市必读：12月31日易明医药现3035.76万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2601886024","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601886024?lang=zh_cn&edition=full","pubTime":"2026-01-05 04:10","pubTimestamp":1767557422,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，易明医药报收于18.38元，上涨1.72%，换手率2.78%，成交量4.84万手，成交额8905.91万元。当日关注点来自交易信息汇总：12月31日主力资金净流入583.16万元，占总成交额6.55%。来自交易信息汇总：当日易明医药发生3035.76万元大宗交易。大宗交易12月31日易明医药现3035.76万元大宗交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010500001362.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0056","BK0033"],"gpt_icon":0},{"id":"2600706086","title":"每周股票复盘：12月31日易明医药（002826）现3035.76万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2600706086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600706086?lang=zh_cn&edition=full","pubTime":"2026-01-03 03:18","pubTimestamp":1767381536,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，易明医药（002826）报收于18.38元，较上周的18.05元上涨1.83%。本周，易明医药12月31日盘中最高价报18.77元。12月29日盘中最低价报17.81元。易明医药当前最新总市值35.05亿元，在化学制药板块市值排名124/150，在两市A股市值排名4243/5181。本周关注点交易信息汇总：12月31日易明医药现3035.76万元大宗交易交易信息汇总12月31日易明医药现3035.76万元大宗交易以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300002127.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","002826","BK0239"],"gpt_icon":0},{"id":"2595842720","title":"12月31日易明医药现3035.76万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2595842720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595842720?lang=zh_cn&edition=full","pubTime":"2025-12-31 17:33","pubTimestamp":1767173602,"startTime":"0","endTime":"0","summary":"证券之星消息，12月31日易明医药发生大宗交易，交易数据如下：近三个月该股共发生2笔大宗交易，合计成交1.68万手，折价成交2笔。该股近期无解禁股上市。截至2025年12月31日收盘，易明医药(002826)报收于18.38元，上涨1.72%，换手率2.78%，成交量4.84万手，成交额8905.91万元。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025123100031399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0056","BK0033"],"gpt_icon":0},{"id":"2594409943","title":"股市必读：易明医药(002826)股东户数1.81万户，较上期减少2.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594409943","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594409943?lang=zh_cn&edition=full","pubTime":"2025-12-25 02:40","pubTimestamp":1766601621,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘，易明医药报收于18.03元，下跌0.17%，换手率1.13%，成交量1.97万手，成交额3564.02万元。交易信息汇总资金流向12月24日主力资金净流出635.79万元；游资资金净流入428.67万元；散户资金净流入207.12万元。股本股东变化股东户数变动截至2025年12月19日，易明医药股东户数为1.81万户，较12月10日减少433户，降幅2.34%；户均持股数量升至1.06万股，户均持股市值为19.28万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500001313.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0033","BK0056","BK0239"],"gpt_icon":0},{"id":"2593444031","title":"易明医药：截至2025年12月19日股东数为18,066户","url":"https://stock-news.laohu8.com/highlight/detail?id=2593444031","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593444031?lang=zh_cn&edition=full","pubTime":"2025-12-24 08:54","pubTimestamp":1766537655,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至12月20日的股东人数是多少？谢谢易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司最新下发的股东名册，截至2025年12月19日，本公司股东数为18,066户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400006299.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","BK0239","002826"],"gpt_icon":0},{"id":"2590217155","title":"易明医药：截至2025年12月10日股东数为18,499户","url":"https://stock-news.laohu8.com/highlight/detail?id=2590217155","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590217155?lang=zh_cn&edition=full","pubTime":"2025-12-12 11:36","pubTimestamp":1765510586,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)12月11日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2025年12月10日公司股东人数多少？易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2025年12月10日，本公司股东数为18,499户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121200013663.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0239","BK0033"],"gpt_icon":0},{"id":"2588474387","title":"易明医药：截至2025年11月28日股东数为18,604户","url":"https://stock-news.laohu8.com/highlight/detail?id=2588474387","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588474387?lang=zh_cn&edition=full","pubTime":"2025-12-01 16:12","pubTimestamp":1764576729,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药(002826)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至11月28日收盘公司的股东人数是多少？谢谢易明医药回复：尊敬的投资者，您好。根据中登结算深圳分公司下发的股东名册，截至2025年11月28日，本公司股东数为18,604户。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100015280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0056","BK0033","BK0239"],"gpt_icon":0},{"id":"2585446839","title":"易明医药(002826)11月20日股东户数1.89万户，较上期减少10.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585446839","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585446839?lang=zh_cn&edition=full","pubTime":"2025-11-24 17:48","pubTimestamp":1763977694,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2025年11月20日公司股东户数为1.89万户，较10月31日减少2223.0户，减幅为10.51%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至11月20日，化学制药行业平均股东户数为3.44万户。从股价来看，2025年10月31日至2025年11月20日，易明医药区间跌幅为4.77%，在此期间股东户数减少2223.0户，减幅为10.51%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400022654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0056","BK0239","BK0033"],"gpt_icon":0},{"id":"2585311872","title":"易明医药：公司目前没有收购58同城或转转相关资产的计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2585311872","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585311872?lang=zh_cn&edition=full","pubTime":"2025-11-21 16:25","pubTimestamp":1763713542,"startTime":"0","endTime":"0","summary":"公司目前没有通过增发收购、协议收购或增发募资方式收购58同城或者转转等相关资产的计划；上市公司股价受宏观经济、市场环境变化等多种因素影响，敬请投资者理性投资，注意投资风险；公司在秉持平稳、安全运营的前提下，集中资源大力发展现有业务，促进公司稳健发展；公司设有董事会办公室负责投资者关系管理和合规事务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100019959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","BK0033","BK0239","002826"],"gpt_icon":0},{"id":"2581819410","title":"股市必读：易明医药(002826)股东户数2.11万户，较上期增加6.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581819410","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581819410?lang=zh_cn&edition=full","pubTime":"2025-11-06 08:06","pubTimestamp":1762387617,"startTime":"0","endTime":"0","summary":"h2,h3,h4{padding: 10px 0;font-size: 16px;line-height: 30px;color:#262626;font-weight: 600;}h2{border-bottom: 1px solid #d8dee4; padding-bottom: 0.3em}.article_content ul{padding-left:22px;}截至2025年11月5日收盘，易明医药报收于20.22元，下跌0.15%，换手率1.91%，成交量3.32万手，成交额6698.95万元。来自：截至2025年10月31日股东户数环比增长6.1%，户均持股数量下降至9017.0股，表明筹码趋于分散。资金流向11月5日主力资金净流出663.23万元；游资资金净流入336.13万元；散户资金净流入327.1万元。股东户数变动近日易明医药披露，截至2025年10月31日公司股东户数为2.11万户，较10月20日增加1216.0户，增幅为6.1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251106/31771328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002826","BK0033","BK0056","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1771117694142,"stockEarnings":[{"period":"1week","weight":-0.0487},{"period":"1month","weight":0.0815},{"period":"3month","weight":0.012},{"period":"6month","weight":-0.1306},{"period":"1year","weight":0.8086},{"period":"ytd","weight":0.1045}],"compareEarnings":[{"period":"1week","weight":0.0041},{"period":"1month","weight":-0.0107},{"period":"3month","weight":0.0229},{"period":"6month","weight":0.1042},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0285}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"西藏易明西雅医药科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"17706人(较上一季度增加0.18%)","perCapita":"9845股","listingDate":"2016-12-09","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区林琼岗路6号","registeredCapital":"19067万元","survey":"　　西藏易明西雅医药科技股份有限公司的主营业务是糖尿病、心血管疾病等老年慢性病症治疗及妇科领域核心产品的开发和研究。公司的主要产品是米格列醇片、醋氯芬酸肠溶片、蒙脱石散、红金消结片、多潘立酮片、阿奇霉素胶囊、氯雷他定片、注射用多种维生素（12）、多种微量元素注射液。截至报告期末，公司拥有发明专利28件，实用新型专利22件，药品注册批件32件，注册商标83件。","listedPrice":6.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"易明医药,002826,易明医药股票,易明医药股票老虎,易明医药股票老虎国际,易明医药行情,易明医药股票行情,易明医药股价,易明医药股市,易明医药股票价格,易明医药股票交易,易明医药股票购买,易明医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}